ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Apr 6, 2016
Insider Transaction Report
Form 4
Selby Brian L.
VP, Finance
Transactions
- Sale
Common Stock
2016-04-04$3.52/sh−1,114$3,921→ 3,026 total
Footnotes (2)
- [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Equity Incentive Plan (the "Plan").
- [F2]Includes (i) remaining 476 previously reported shares issued as RSUs under the Plan that vests on 9/17/16, (ii) remaining 322 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning on 2/27/17, and (iii) 2,228 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning 4/2/17, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan.